夢網集團(002123.SZ):授權擇機處置認購的高瀾股份可轉債及其不超305.475萬股股份
格隆匯 8 月 16日丨夢網集團(002123.SZ)公佈,公司於2020年8月16日召開了第七屆董事會第二十四次會議,審議通過了《關於認購高瀾股份A股可轉債暨授權公司管理層處置金融資產的議案》,同意授權公司管理層根據市場環境等確定交易價格、交易數量,通過二級市場擇機處置此次認購的廣州高瀾節能技術股份有限公司(“高瀾股份”)可轉換公司債券及所持有的高瀾股份不超過305.475萬股股份,授權期間自董事會審議通過之日起一年。若此期間高瀾股份有送股、資本公積轉增股本等股份變動事項,對該股份做同等處理。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.